[Complete hormonal and metabolic response after iodine-131 metaiodobenzylguanidine treatment in a patient diagnosed of malignant pheochromocytoma]. / Respuesta hormonal y metabólica completa tras el tratamiento con yodo-131 metayodobencilguanidina en un caso de feocromocitoma maligno.
Rev Esp Med Nucl Imagen Mol
; 32(6): 390-3, 2013.
Article
em Es
| MEDLINE
| ID: mdl-23562188
ABSTRACT
Radiolabeled metaiodobenzylguanidine is an analogue of norepinephrine used to localize tumors that express the neurohormone transporters, specifically those derived from the neural crest having a neuroendocrine origin. It is also used to treat non-surgical metastases derived from them. A review of the literature revealed symptomatic improvements associated to a decrease in hormone levels in a significant percentage of patients after (131)I-MIBG treatment. However, complete tumor remission has been described only in very few cases and hardly ever when bone metastases exist. We present a case of a patient diagnosed of malignant pheochromocytoma who achieved complete hormonal and metabolic response after (131)I-MIBG treatment (600 mCi) in spite of the presence of bone metastases.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Feocromocitoma
/
Neoplasias das Glândulas Suprarrenais
/
3-Iodobenzilguanidina
/
Antineoplásicos
Tipo de estudo:
Diagnostic_studies
Limite:
Adult
/
Humans
/
Male
Idioma:
Es
Ano de publicação:
2013
Tipo de documento:
Article